CA Stock MarketDetailed Quotes

ATE Antibe Therapeutics Inc

Watchlist

0.295
0.0000.00%

15min DelayMarket Closed Apr 10 09:30 ET

15.64MMarket Cap-842P/E (TTM)

Antibe Therapeutics Inc Key Stats

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

(Q2)Sep 30, 2022

(Q1)Jun 30, 2022

(FY)Mar 31, 2022

(Q4)Mar 31, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-41.20%24.91M

-38.62%27.88M

-31.64%34.31M

-29.04%38.89M

-27.74%42.36M

-24.95%45.41M

-24.89%50.19M

-23.88%54.81M

-Cash and cash equivalents

7.69%11.34M

-69.54%4.14M

-52.59%8.79M

-80.59%6.76M

-82.03%10.53M

-77.51%13.6M

-72.23%18.55M

-51.64%34.81M

-Short term investments

-57.37%13.57M

-25.39%23.73M

-19.36%25.51M

60.69%32.14M

127,204.00%31.83M

127,140.00%31.81M

126,460.00%31.64M

79,900.00%20M

Receivables

121.83%1.5M

287.14%1.6M

148.76%1.5M

44.07%1.62M

-36.10%678K

-74.23%412K

-76.20%603K

-56.62%1.12M

-Accounts receivable

----

--0

-Loans receivable

----

--159K

----

-Accrued interest receivable

9.85%435K

--449K

--318K

16,833.33%508K

--396K

--0

--3K

-Taxes receivable

-31.21%194K

7.11%271K

-30.86%307K

-83.36%186K

-73.42%282K

-84.18%253K

-71.86%444K

-26.59%1.12M

-Other receivables

--875K

--921K

----

Inventory

----

--0

Prepaid assets

172.65%1.69M

105.04%1.63M

188.43%1.97M

29.23%1.04M

-29.37%618K

-2.10%794K

-69.29%683K

-65.99%804K

Current deferred assets

----

--875K

----

Holding assets for sale

----

--0

-4.47%4.92M

--4.38M

--4.63M

Total current assets

-36.90%28.1M

-39.65%31.1M

-32.36%37.78M

-32.30%41.55M

-31.15%44.53M

-24.28%51.54M

-24.49%55.85M

-22.43%61.36M

Non current assets

Net PPE

----

--0

Non current accounts receivable

-55.15%632K

--1.47M

--1.43M

--1.38M

--1.41M

----

Non current note receivables

----

--0

0.00%159K

--0

1.27%159K

Non current prepaid assets

----

--0

Goodwill and other intangible assets

0.00%26.35M

-2.99%26.35M

2,932.45%26.35M

-Other intangible assets

----

0.00%26.35M

----

0.00%26.35M

----

2,932.45%26.35M

Non current deferred assets

0.00%1.28M

Total non current assets

-3.21%28.27M

5.32%29.11M

5.16%29.06M

4.39%29.02M

5.07%29.2M

-0.57%27.64M

-4.35%27.64M

953.60%27.79M

Total assets

-23.56%56.36M

-23.95%60.21M

-19.94%66.84M

-20.86%70.56M

-20.26%73.73M

-17.41%79.17M

-18.83%83.49M

9.07%89.16M

Liabilities

Current liabilities

-Current capital lease obligation

----

--0

Other current liabilities

----

-16.70%1.65M

--1.53M

--1.88M

Current liabilities

-1.45%2.79M

-39.90%2.87M

15.72%4.41M

-41.12%2.76M

-21.49%2.84M

33.04%4.77M

11.24%3.81M

25.47%4.69M

Non current liabilities

Long term debt and capital lease obligation

----

--0

-Long term capital lease obligation

----

--0

Non current deferred liabilities

0.00%27.63M

Total non current liabilities

0.00%27.63M

-0.26%27.63M

-0.38%27.63M

Total liabilities

-0.13%30.43M

-5.87%30.5M

1.91%32.04M

-5.97%30.4M

-2.48%30.47M

3.79%32.4M

1.01%31.44M

2.69%32.33M

Shareholders'equity

Share capital

0.53%141.61M

1.37%141.58M

1.44%141.58M

1.39%141.49M

2.03%140.87M

1.24%139.67M

1.37%139.57M

25.07%139.55M

-common stock

0.53%141.61M

1.37%141.58M

1.44%141.58M

1.39%141.49M

2.03%140.87M

1.24%139.67M

1.37%139.57M

25.07%139.55M

Additional paid-in capital

2.55%19.56M

-1.62%19.15M

2.50%19.23M

4.80%18.9M

2.17%19.08M

12.20%19.46M

17.66%18.76M

26.20%18.04M

Retained earnings

-14.62%-145.5M

-15.22%-141.29M

-16.93%-136.28M

-17.54%-130.49M

-20.01%-126.94M

-21.50%-122.63M

-26.33%-116.55M

-29.15%-111.02M

Other equity interest

0.00%10.26M

-0.86%10.26M

Total stockholders'equity

-40.05%25.94M

-36.48%29.71M

-33.14%34.8M

-29.33%40.17M

-29.34%43.26M

-27.65%46.77M

-27.44%52.05M

13.07%56.83M

Total equity

-40.05%25.94M

-36.48%29.71M

-33.14%34.8M

-29.33%40.17M

-29.34%43.26M

-27.65%46.77M

-27.44%52.05M

13.07%56.83M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022	(Q2)Sep 30, 2022	(Q1)Jun 30, 2022	(FY)Mar 31, 2022	(Q4)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-41.20%24.91M	-38.62%27.88M	-31.64%34.31M	-29.04%38.89M	-29.04%38.89M	-27.74%42.36M	-24.95%45.41M	-24.89%50.19M	-23.88%54.81M	-23.88%54.81M
-Cash and cash equivalents	7.69%11.34M	-69.54%4.14M	-52.59%8.79M	-80.59%6.76M	-80.59%6.76M	-82.03%10.53M	-77.51%13.6M	-72.23%18.55M	-51.64%34.81M	-51.64%34.81M
-Short term investments	-57.37%13.57M	-25.39%23.73M	-19.36%25.51M	60.69%32.14M	60.69%32.14M	127,204.00%31.83M	127,140.00%31.81M	126,460.00%31.64M	79,900.00%20M	79,900.00%20M
Receivables	121.83%1.5M	287.14%1.6M	148.76%1.5M	44.07%1.62M	44.07%1.62M	-36.10%678K	-74.23%412K	-76.20%603K	-56.62%1.12M	-56.62%1.12M
-Accounts receivable	----	----	----	----	----	----	----	----	--0	--0
-Loans receivable	----	----	----	----	----	----	--159K	--159K	----	----
-Accrued interest receivable	9.85%435K	--449K	--318K	16,833.33%508K	16,833.33%508K	--396K	--0	--0	--3K	--3K
-Taxes receivable	-31.21%194K	7.11%271K	-30.86%307K	-83.36%186K	-83.36%186K	-73.42%282K	-84.18%253K	-71.86%444K	-26.59%1.12M	-26.59%1.12M
-Other receivables	--875K	--875K	--875K	--921K	--921K	----	----	----	----	----
Inventory	----	----	----	----	----	----	----	----	--0	--0
Prepaid assets	172.65%1.69M	105.04%1.63M	188.43%1.97M	29.23%1.04M	29.23%1.04M	-29.37%618K	-2.10%794K	-69.29%683K	-65.99%804K	-65.99%804K
Current deferred assets	----	----	----	----	----	--875K	----	----	----	----
Holding assets for sale	----	----	----	--0	--0	--0	-4.47%4.92M	--4.38M	--4.63M	--4.63M
Total current assets	-36.90%28.1M	-39.65%31.1M	-32.36%37.78M	-32.30%41.55M	-32.30%41.55M	-31.15%44.53M	-24.28%51.54M	-24.49%55.85M	-22.43%61.36M	-22.43%61.36M
Non current assets
Net PPE	----	----	----	----	----	----	----	----	--0	--0
Non current accounts receivable	-55.15%632K	--1.47M	--1.43M	--1.38M	--1.38M	--1.41M	----	----	----	----
Non current note receivables	----	----	----	--0	--0	0.00%159K	--0	--0	1.27%159K	1.27%159K
Non current prepaid assets	----	----	----	----	----	----	----	----	--0	--0
Goodwill and other intangible assets	0.00%26.35M	0.00%26.35M	0.00%26.35M	0.00%26.35M	0.00%26.35M	0.00%26.35M	0.00%26.35M	-2.99%26.35M	2,932.45%26.35M	2,932.45%26.35M
-Other intangible assets	----	----	----	0.00%26.35M	0.00%26.35M	----	0.00%26.35M	----	2,932.45%26.35M	2,932.45%26.35M
Non current deferred assets	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M	0.00%1.28M
Total non current assets	-3.21%28.27M	5.32%29.11M	5.16%29.06M	4.39%29.02M	4.39%29.02M	5.07%29.2M	-0.57%27.64M	-4.35%27.64M	953.60%27.79M	953.60%27.79M
Total assets	-23.56%56.36M	-23.95%60.21M	-19.94%66.84M	-20.86%70.56M	-20.86%70.56M	-20.26%73.73M	-17.41%79.17M	-18.83%83.49M	9.07%89.16M	9.07%89.16M
Liabilities
Current liabilities
-Current capital lease obligation	----	----	----	----	----	----	----	----	--0	--0
Other current liabilities	----	----	----	----	----	----	-16.70%1.65M	--1.53M	--1.88M	--1.88M
Current liabilities	-1.45%2.79M	-39.90%2.87M	15.72%4.41M	-41.12%2.76M	-41.12%2.76M	-21.49%2.84M	33.04%4.77M	11.24%3.81M	25.47%4.69M	25.47%4.69M
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	----	----	----	----	--0	--0
-Long term capital lease obligation	----	----	----	----	----	----	----	----	--0	--0
Non current deferred liabilities	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M
Total non current liabilities	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	0.00%27.63M	-0.26%27.63M	-0.38%27.63M	-0.38%27.63M
Total liabilities	-0.13%30.43M	-5.87%30.5M	1.91%32.04M	-5.97%30.4M	-5.97%30.4M	-2.48%30.47M	3.79%32.4M	1.01%31.44M	2.69%32.33M	2.69%32.33M
Shareholders'equity
Share capital	0.53%141.61M	1.37%141.58M	1.44%141.58M	1.39%141.49M	1.39%141.49M	2.03%140.87M	1.24%139.67M	1.37%139.57M	25.07%139.55M	25.07%139.55M
-common stock	0.53%141.61M	1.37%141.58M	1.44%141.58M	1.39%141.49M	1.39%141.49M	2.03%140.87M	1.24%139.67M	1.37%139.57M	25.07%139.55M	25.07%139.55M
Additional paid-in capital	2.55%19.56M	-1.62%19.15M	2.50%19.23M	4.80%18.9M	4.80%18.9M	2.17%19.08M	12.20%19.46M	17.66%18.76M	26.20%18.04M	26.20%18.04M
Retained earnings	-14.62%-145.5M	-15.22%-141.29M	-16.93%-136.28M	-17.54%-130.49M	-17.54%-130.49M	-20.01%-126.94M	-21.50%-122.63M	-26.33%-116.55M	-29.15%-111.02M	-29.15%-111.02M
Other equity interest	0.00%10.26M	0.00%10.26M	0.00%10.26M	0.00%10.26M	0.00%10.26M	0.00%10.26M	0.00%10.26M	-0.86%10.26M	-0.86%10.26M	-0.86%10.26M
Total stockholders'equity	-40.05%25.94M	-36.48%29.71M	-33.14%34.8M	-29.33%40.17M	-29.33%40.17M	-29.34%43.26M	-27.65%46.77M	-27.44%52.05M	13.07%56.83M	13.07%56.83M
Total equity	-40.05%25.94M	-36.48%29.71M	-33.14%34.8M	-29.33%40.17M	-29.33%40.17M	-29.34%43.26M	-27.65%46.77M	-27.44%52.05M	13.07%56.83M	13.07%56.83M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List

Overall

No Data

ATE Antibe Therapeutics Inc

Antibe Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow